BDB-001 (Eikon Therapeutics)

N/A

Report date: 2026/05/21 20:00:22
NME

Base Information

Drug NameBDB-001 (Eikon Therapeutics)
Drug Alias NameBDB001 (Eikon Therapeutics)EIK-1001EIK1001
ClassificationOther
Mechanisms of ActionToll like receptor 7 agonistsToll like receptor 8 agonists
TargetsToll like receptor 7Toll like receptor 8
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungLung Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[24] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBirdie Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesEikon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungLung Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A